FI972306A - Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning - Google Patents

Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning Download PDF

Info

Publication number
FI972306A
FI972306A FI972306A FI972306A FI972306A FI 972306 A FI972306 A FI 972306A FI 972306 A FI972306 A FI 972306A FI 972306 A FI972306 A FI 972306A FI 972306 A FI972306 A FI 972306A
Authority
FI
Finland
Prior art keywords
diozide
arylcarbonyloxymethyl
onei
thiadiazolidin
derivatives
Prior art date
Application number
FI972306A
Other languages
English (en)
Finnish (fi)
Other versions
FI972306A0 (sv
Inventor
Ranjit C Desai
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of FI972306A0 publication Critical patent/FI972306A0/sv
Publication of FI972306A publication Critical patent/FI972306A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems
FI972306A 1994-12-02 1997-05-30 Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning FI972306A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/349,341 US5556909A (en) 1994-12-02 1994-12-02 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
PCT/US1995/015504 WO1996016951A1 (en) 1994-12-02 1995-11-30 Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof

Publications (2)

Publication Number Publication Date
FI972306A0 FI972306A0 (sv) 1997-05-30
FI972306A true FI972306A (sv) 1997-05-30

Family

ID=23371974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972306A FI972306A (sv) 1994-12-02 1997-05-30 Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning

Country Status (12)

Country Link
US (1) US5556909A (sv)
EP (1) EP0801648A4 (sv)
JP (1) JPH10509979A (sv)
CN (1) CN1173175A (sv)
AU (1) AU703622B2 (sv)
CA (1) CA2205837A1 (sv)
FI (1) FI972306A (sv)
HU (1) HUT77364A (sv)
MX (1) MX9704034A (sv)
NO (1) NO972449L (sv)
NZ (1) NZ298266A (sv)
WO (1) WO1996016951A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420401B1 (en) 1997-08-22 2002-07-16 Wichita State University 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
DOP2000000107A (es) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
GB0225986D0 (en) * 2002-11-07 2002-12-11 Astrazeneca Ab Chemical compounds
EP1567487A4 (en) * 2002-11-15 2005-11-16 Bristol Myers Squibb Co OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
US7432292B2 (en) 2002-12-30 2008-10-07 Vertex Pharmaceuticals Incorporated Sulfhydantoins as phosphate isosteres
US7256208B2 (en) * 2003-11-13 2007-08-14 Bristol-Myers Squibb Company Monocyclic N-Aryl hydantoin modulators of androgen receptor function
US20050182105A1 (en) * 2004-02-04 2005-08-18 Nirschl Alexandra A. Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
US7820702B2 (en) * 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7696241B2 (en) * 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en) * 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
WO2020219720A1 (en) * 2019-04-23 2020-10-29 The Cleveland Clinic Foundation Allosteric activators of the alpha1a -adrenergic receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
DE4141218A1 (de) * 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5550139A (en) * 1994-01-03 1996-08-27 The Wichita State University Serine protease inhibitors

Also Published As

Publication number Publication date
EP0801648A4 (en) 1998-01-28
FI972306A0 (sv) 1997-05-30
NZ298266A (en) 1998-11-25
EP0801648A1 (en) 1997-10-22
CN1173175A (zh) 1998-02-11
WO1996016951A1 (en) 1996-06-06
AU4371096A (en) 1996-06-19
CA2205837A1 (en) 1996-06-06
JPH10509979A (ja) 1998-09-29
NO972449D0 (no) 1997-05-29
US5556909A (en) 1996-09-17
HUT77364A (hu) 1998-03-30
AU703622B2 (en) 1999-03-25
NO972449L (no) 1997-07-22
MX9704034A (es) 1998-02-28

Similar Documents

Publication Publication Date Title
FI923321A (fi) Komposition foer ihaollande och kontrollerad avgivning av medikamentartad aemne
FI941274A0 (fi) Foerfarande och anordning foer montering av laettelement
FI895910A0 (fi) Antiseptiska kompositioner och foerfarande foer deras framstaellning.
FI932625A0 (fi) Anordning och foerfarande foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter
FI960483A0 (sv) Föränderlig sammansättning och förfaranden för användning av denna
FI972306A (sv) Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning
FI931161A (fi) Kompositioner innehaollande estrar av karboxylhaltiga interpolymerer och anvaendning av dessa
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
FI971462A0 (sv) Bensioxazolderivat och bekämpningsmedelssammansättningar innehållande desamma
FI922389A (fi) Anordning foer framstaellning av en pressmantel avsedd foer bruk i pappersindustrin och pressmantel framstaelld daermed
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI945945A0 (fi) Foerfarande och anordning foer uppslamning av finfoerdelade aemnen i vaetska
FI954743A0 (sv) Sammansättningar med difluormetoxi-2,2,2-trifluoretan
FI972310A (sv) Substituerade 2-(fosfinyloximetyl)-1,2,5-tiadiazolidin-3-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras användning
FI972307A (sv) 2-(2,3,5,6-tetrafluor-4-pyridyl)1,2,5-tiadiazolidin-3-oni-1,1-dioxider och dessa innehållande kompositioner och förfarande för deras användning
FI924756A (fi) 1,5-benzotiazepinonderivat, deras framstaellning och farmaceutiska anvaendning
FI972702A (sv) Ny klatratförening och framställningsförfarande för densamma och bestrykningskomposition innehållande denna förening
FI944282A0 (fi) Foerfarande och kretsarrangemang foer foerverkligande av oemsesidig tidsanpassning foer mikroprocessoranordning och daertill kopplade styranordningar
FI930967A0 (fi) Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner
FI935627A0 (fi) Foerfarande foer framstaellning av foderraomaterial, foderraomaterial och anordning foer behandling av material innehaollande keratin
FI930697A0 (fi) Foerfarande och komposition foer behandling av virusinjektion
SE9400371L (sv) Kompositioner för inhalation
FI1506U1 (fi) Braennbart uppvaermningsredskap foer bruk utomhus och i eldstaeder
FI945314A (sv) Tetrazolderivat, deras framställning och användning
FI945335A0 (fi) Foerfarande foer framstaellning av en ljudabsorberande yta och ljudabsorberande yta